M&A Deal Summary

Grupo Farmaceutico Biotoscana Acquires Laboratorio LKM SA

On December 21, 2015, Grupo Farmaceutico Biotoscana acquired life science company Laboratorio LKM SA from Advent International

Acquisition Highlights
  • This is Grupo Farmaceutico Biotoscana’s 1st transaction in the Life Science sector.
  • This is Grupo Farmaceutico Biotoscana’s 1st transaction in Argentina.

M&A Deal Summary

Date 2015-12-21
Target Laboratorio LKM SA
Sector Life Science
Buyer(s) Grupo Farmaceutico Biotoscana
Sellers(s) Advent International
Deal Type Add-on Acquisition

Target

Laboratorio LKM SA

Ciudad de Buenos Aires, Argentina
Laboratorio LKM S.A. (LKM) is a specialty pharmaceutical manufacturer in Argentina.

Search 214,239 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Grupo Farmaceutico Biotoscana

Montevideo, Uruguay

Category Company
Founded 1994
Sector Life Science
Employees677
Revenue 437M EUR (2018)
DESCRIPTION

Grupo Farmaceutico Biotoscana is a biopharmaceutical group that focuses on rapidly growing market segments such as infectious diseases, oncology and onco-hematology, special treatments, immunology and inflammation, and orphan/rare diseases, among others. Grupo Farmaceutico Biotoscana was formed in 1994 and is based in Montevideo, Uruguay.


DEAL STATS #
Overall 1 of 1
Sector: Life Science M&A 1 of 1
Type: Add-on Acquisition M&A Deals 1 of 1
Country: Argentina M&A 1 of 1
Year: 2015 M&A 1 of 1

Seller(S) 1

SELLER

Advent International

Boston, Massachusetts, United States

Investor Investor Investor Investor Investor


Category Private Equity Firm
Founded 1984
PE ASSETS 91.0B USD
Size Mega
Type Sector Agnostic
DESCRIPTION

Advent is a global private equity firm that targets investments in North America, Europe, Asia, and Latin America. Advent's emerging market efforts are concentrated in Central Europe and Latin America. Advent seeks transactions valued between $50 million and $5 billion and can commit up to $2 billion of equity capital per investment. Broad areas of interest include business & financial services, retail & consumer, technology, media, & telecoms, healthcare & life sciences, and industrial. Prospective transaction types include buyouts, growth capital financings, take privates, and recapitalizations. Advent was formed in 1984 and is based in Boston, Massachusetts.


DEAL STATS #
Overall 159 of 233
Sector: Life Science M&A 10 of 13
Type: Add-on Acquisition M&A Deals 60 of 87
Country: Argentina M&A 4 of 4
Year: 2015 M&A 13 of 13
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2015-11-23 Planet

Galway, Ireland

Planet is a provider of VAT refund and dynamic currency conversion (“DCC”) services to retailers, governments, and financial institutions globally. Planet is based in Galway, Ireland.

Buy €585M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2016-01-01 Brammer

Knutsford, United Kingdom

Brammer plc is a distribution company offering a single source of supply, with an unrivalled and competitively priced product range from the world’s most respected manufacturers, supported by online ordering and a state of the art distribution network. Brammer draws on a rich heritage of industrial and mechanical knowledge. Company serve more than 100,000 customers in every manufacturing sector, leveraging pan-European network and offering added value technical expertise combined with in-depth, industry specific understanding on a regional and local level.

Buy £222M